# Imaging Malignant Glioma With 68Ga-DOTATOC PET/CT

> **NCT01460706** · PHASE2,PHASE3 · COMPLETED · sponsor: **Turku University Hospital** · enrollment: 30 (actual)

## Conditions studied

- Glioma

## Interventions

- **DRUG:** [68Ga]DOTATOC

## Key facts

- **NCT ID:** NCT01460706
- **Lead sponsor:** Turku University Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01460706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01460706, "Imaging Malignant Glioma With 68Ga-DOTATOC PET/CT". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01460706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*